|
|
Volumn 8, Issue 3, 2008, Pages 219-221
|
|
Novel targets and drugs in inflammatory lung disease
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BRONCHODILATING AGENT;
CHEMOKINE RECEPTOR ANTAGONIST;
CORTICOSTEROID;
GLUCOCORTICOID;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
MACROLIDE;
SMALL INTERFERING RNA;
THEOPHYLLINE;
ASTHMA;
BEHAVIOR;
CHRONIC BRONCHITIS;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CIGARETTE SMOKING;
CYSTIC FIBROSIS;
DISEASE SEVERITY;
EDITORIAL;
EMPHYSEMA;
EOSINOPHILIA;
HUMAN;
INCIDENCE;
MOOD;
NEUTROPHILIA;
NUTRITIONAL SUPPORT;
OXIDATIVE STRESS;
PATHOPHYSIOLOGY;
PHYSIOTHERAPY;
PRIORITY JOURNAL;
PROGNOSIS;
RESPIRATORY TRACT INFLAMMATION;
SIDE EFFECT;
UNSPECIFIED SIDE EFFECT;
ASTHMA;
CYSTIC FIBROSIS;
HUMANS;
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;
|
|
EID: 44649140424
PISSN: 14714892
EISSN: None
Source Type: Journal
DOI: 10.1016/j.coph.2008.04.007 Document Type: Editorial |
|
Times cited : (8)
|
|
References (0)
|
